Point72 Asset Management
WST icon

Point72 Asset Management’s West Pharmaceutical WST Stock Holding History

Point72 Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$330K – 4602
2025
Q4 		$330K Buy
+1,200
New +$328K ﹤0.01% 3439
2024
Q2 		– Sell
-20,000
Closed -$7.91M – 2521
2024
Q1 		$7.91M Buy
+20,000
New +$7.4M 0.02% 803

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Point72 Asset Management's WST Position: Q2 2026 in Review

Point72 Asset Management increased its West Pharmaceutical (WST) stake by 78% in Q2 2026, buying an estimated $37.9M and bringing the position to 283,396 shares worth $102M. The position accounts for 0.11% of the portfolio, ranked #200.

Point72 Asset Management first reported a position in WST in Q2 2019 and has held it in 22 quarters since. The position peaked at $173M in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Point72 Asset Management held 283,396 shares of West Pharmaceutical worth $102M as of Q2 2026.
  • Point72 Asset Management bought 124,046 West Pharmaceutical shares in Q2 2026, an estimated $37.9M.
  • West Pharmaceutical made up 0.11% of Point72 Asset Management's portfolio in Q2 2026, its #200 holding.
  • Point72 Asset Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 22 quarters since.
  • Point72 Asset Management's West Pharmaceutical position peaked at $173M in Q3 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.